[Drug therapy in tardive dyskinesia].
D003937:Diagnosis, Differential; D018492:Dopamine Antagonists; D004409:Dyskinesia, Drug-Induced / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008750:Methyldopa / Q000627:therapeutic use; D010277:Parasympathomimetics / Q000627:therapeutic use; D011736:Pyridoxine / Q000627:therapeutic use; D013976:Tiapamil Hydrochloride / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000627:therapeutic use; D014364:Tryptophan / Q000627:therapeutic use
D018492:Dopamine Antagonists; D010277:Parasympathomimetics; D014149:Tranquilizing Agents; D008750:Methyldopa; D014364:Tryptophan; D008094:Lithium; D011736:Pyridoxine; D013976:Tiapamil Hydrochloride
Medikamentöse Therapie der Spätdyskinesien.